MiFID II in the US: firms explore research unbundling options

Practice Insight – In an article abour research unbundling, Healthy Markets Executive Director Tyler Gellasch is quoted as saying: “If the SEC clarifies what its CSA means and who can accept payment from it then they are removing a regulatory burden, but that does not mean that large banks won’t compel firms to keep trading with them in order to get their research,” he said. “It just removes the crutch of saying the law or the SEC prevents us from being able to accept commission sharing payments.” (Full Story).

Reader Interactions